Znanstveni rad - Izvorni znanstveni rad
Cost effectiveness of antihypertensive drugs and treatment guidelines
European Journal of Clinical Pharmacology, 77 (2021); 1665-1672. https://doi.org/10.1007/s00228-021-03163-4


Citirajte ovaj rad

Kučan, M., Lulić, I., Mršić Pelčić, J., Mozetič, V. i Vitezić, D. (2021). Cost effectiveness of antihypertensive drugs and treatment guidelines. European Journal of Clinical Pharmacology, 77., 1665-1672. doi: 10.1007/s00228-021-03163-4

Kučan, Marta, et al. "Cost effectiveness of antihypertensive drugs and treatment guidelines." European Journal of Clinical Pharmacology, vol. 77, 2021, str. 1665-1672. https://doi.org/10.1007/s00228-021-03163-4

Kučan, Marta, Igor Lulić, Jasenka Mršić Pelčić, Vladimir Mozetič i Dinko Vitezić. "Cost effectiveness of antihypertensive drugs and treatment guidelines." European Journal of Clinical Pharmacology 77 (2021): 1665-1672. https://doi.org/10.1007/s00228-021-03163-4

Kučan, M., et al. (2021) 'Cost effectiveness of antihypertensive drugs and treatment guidelines', European Journal of Clinical Pharmacology, 77, str. 1665-1672. doi: 10.1007/s00228-021-03163-4

Kučan M, Lulić I, Mršić Pelčić J, Mozetič V, Vitezić D. Cost effectiveness of antihypertensive drugs and treatment guidelines. European Journal of Clinical Pharmacology [Internet]. 2021. [pristupljeno 17.07.2024.];77:1665-1672. doi: 10.1007/s00228-021-03163-4

M. Kučan, I. Lulić, J. Mršić Pelčić, V. Mozetič i D. Vitezić, "Cost effectiveness of antihypertensive drugs and treatment guidelines", European Journal of Clinical Pharmacology, vol. 77, str. 1665-1672, 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:027935. [Citirano: 17.07.2024.]